Browsing Tag
FIRB
2 posts
Can pharma M&A survive Australia’s new national interest doctrine?
Australia’s FIRB blocked Cosette’s $430M takeover of Mayne Pharma. Can foreign pharma buyers still close deals in this new national interest era?
Foreign bidders face new barriers in Australian energy — is regulation the deal breaker?
Foreign capital in Australian energy is facing stricter FIRB oversight and political hurdles. Learn how the Santos deal collapse shows a regulatory wall is rising.